Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Operative R0 resection of diffuse large B-cell lymphoma of the pelvis: a case report.

Wienerroither V, Sauerschnig M, Beham-Schmid C, Mathew E, El-Shabrawi A, Mischinger HJ, Kornprat P.

J Med Case Rep. 2018 Oct 13;12(1):293. doi: 10.1186/s13256-018-1838-1.

2.

Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.

Fechter K, Feichtinger J, Prochazka K, Unterluggauer JJ, Pansy K, Steinbauer E, Pichler M, Haybaeck J, Prokesch A, Greinix HT, Beham-Schmid C, Neumeister P, Thallinger GG, Deutsch AJA.

Sci Rep. 2018 Sep 28;8(1):14528. doi: 10.1038/s41598-018-32972-4.

3.

Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.

Unterluggauer JJ, Prochazka K, Tomazic PV, Huber HJ, Seeboeck R, Fechter K, Steinbauer E, Gruber V, Feichtinger J, Pichler M, Weniger MA, Küppers R, Sill H, Schicho R, Neumeister P, Beham-Schmid C, Deutsch AJA, Haybaeck J.

Blood Cancer J. 2018 Aug 22;8(9):79. doi: 10.1038/s41408-018-0112-5. No abstract available.

4.

Austrian recommendations for the management of polycythemia vera.

Burgstaller S, Buxhofer-Ausch V, Sliwa T, Beham-Schmid C, Gastl G, Geissler K, Melchardt T, Krauth M, Krippl P, Petzer A, Rumpold H, Wölfler A, Gisslinger H.

Wien Klin Wochenschr. 2018 Sep;130(17-18):535-542. doi: 10.1007/s00508-018-1359-3. Epub 2018 Jul 19.

PMID:
30027395
5.

The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.

Jakovic L, Gotic M, Gisslinger H, Soldatovic I, Sefer D, Tirnanic M, Lekovic D, Jovanovic MP, Schalling M, Gisslinger B, Beham-Schmid C, Simonitsch-Klupp I, Thiele J.

Ann Hematol. 2018 Sep;97(9):1581-1590. doi: 10.1007/s00277-018-3344-3. Epub 2018 May 1.

PMID:
29717365
6.

World Health Organisation Classification of Lymphoid Tumours in Veterinary and Human Medicine: a Comparative Evaluation of Gastrointestinal Lymphomas in 61 Cats.

Wolfesberger B, Fuchs-Baumgartinger A, Greß V, Hammer SE, Gradner G, Knödl K, Tichy A, Rütgen BC, Beham-Schmid C.

J Comp Pathol. 2018 Feb;159:1-10. doi: 10.1016/j.jcpa.2017.12.006. Epub 2018 Feb 3.

PMID:
29598998
7.

Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia.

Schwetz V, Trummer C, Friedl C, Beham-Schmid C, Kulnik R, Wölfler A, Horvath K, Wunsch S, Prattes J, Zollner-Schwetz I, Pieber TR, Mader JK, Krause R.

Clin Case Rep. 2017 Nov 28;6(1):78-81. doi: 10.1002/ccr3.1259. eCollection 2018 Jan.

8.

Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib.

Robier C, Beham-Schmid C, Neubauer M.

Clin Chem Lab Med. 2018 Apr 25;56(5):e112-e114. doi: 10.1515/cclm-2017-0836. No abstract available.

PMID:
29252190
9.

Aggressive lymphoma 2016: revision of the WHO classification.

Beham-Schmid C.

Memo. 2017;10(4):248-254. doi: 10.1007/s12254-017-0367-8. Epub 2017 Nov 30. Review.

10.

Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data.

Schalling M, Gleiss A, Gisslinger B, Wölfler A, Buxhofer-Ausch V, Jeryczynski G, Krauth MT, Simonitsch-Klupp I, Beham-Schmid C, Thiele J, Gisslinger H.

Blood Cancer J. 2017 Dec 13;7(12):643. doi: 10.1038/s41408-017-0006-y. No abstract available.

11.

Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.

Prochazka KT, Posch F, Deutsch A, Beham-Schmid C, Stöger H, Abdyli L, Greinix H, Pichler M, Neumeister P.

Br J Haematol. 2018 Oct;183(1):142-146. doi: 10.1111/bjh.14912. Epub 2017 Sep 6. No abstract available.

PMID:
28875547
12.

Chilblain lupus and steroid-responsive pancytopenia precede monosomy 7-linked AML as manifestation of rasopathy.

Klobassa DS, Dworzak MN, Lanz S, Skrabl-Baumgartner A, Beham-Schmid C, Cerroni L, Haas OA, Wlodarski M, Salzer U, Lackner H, Benesch M, Schwinger W, Urban C, Seidel MG.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26724. Epub 2017 Aug 12. No abstract available.

PMID:
28802089
13.

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.

Kashofer K, Gornicec M, Lind K, Caraffini V, Schauer S, Beham-Schmid C, Wölfler A, Hoefler G, Sill H, Zebisch A.

Leuk Lymphoma. 2018 Feb;59(2):501-504. doi: 10.1080/10428194.2017.1339879. Epub 2017 Jun 20. No abstract available.

14.

Recessive grey platelet-like syndrome with unaffected erythropoiesis in the absence of the splice isoform GFI1B-p37.

Schulze H, Schlagenhauf A, Manukjan G, Beham-Schmid C, Andres O, Klopocki E, König EM, Haidl H, Panzer S, Althaus K, Muntean WE, Schwinger W, Urban C, Greinacher A, Bakchoul T, Seidel MG.

Haematologica. 2017 Sep;102(9):e375-e378. doi: 10.3324/haematol.2017.167957. Epub 2017 May 26. No abstract available.

15.

Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.

Jeryczynski G, Thiele J, Gisslinger B, Wölfler A, Schalling M, Gleiß A, Burgstaller S, Buxhofer-Ausch V, Sliwa T, Schlögl E, Geissler K, Krauth MT, Nader A, Vesely M, Simonitsch-Klupp I, Müllauer L, Beham-Schmid C, Gisslinger H.

Am J Hematol. 2017 Sep;92(9):885-891. doi: 10.1002/ajh.24788. Epub 2017 Jun 9.

16.

NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.

Deutsch AJA, Rinner B, Pichler M, Prochazka K, Pansy K, Bischof M, Fechter K, Hatzl S, Feichtinger J, Wenzl K, Frisch MT, Stiegelbauer V, Prokesch A, Krogsdam A, Sill H, Thallinger GG, Greinix HT, Wang C, Beham-Schmid C, Neumeister P.

Cancer Res. 2017 May 1;77(9):2375-2386. doi: 10.1158/0008-5472.CAN-16-2320. Epub 2017 Mar 1.

17.

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.

Gisslinger H, Jeryczynski G, Gisslinger B, Wölfler A, Burgstaller S, Buxhofer-Ausch V, Schalling M, Krauth MT, Schiefer AI, Kornauth C, Simonitsch-Klupp I, Beham-Schmid C, Müllauer L, Thiele J.

Leukemia. 2017 Mar;31(3):774-775. doi: 10.1038/leu.2016.291. No abstract available.

PMID:
28248312
18.

Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.

Sliwa T, Beham-Schmid C, Burgstaller S, Buxhofer-Ausch V, Gastl G, Geissler K, Krauth M, Krippl P, Lang A, Petzer A, Wöhrer S, Wölfler A, Gisslinger H.

Wien Klin Wochenschr. 2017 May;129(9-10):293-302. doi: 10.1007/s00508-016-1120-8. Epub 2016 Dec 13.

PMID:
27966016
19.

Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'.

Gisslinger H, Jeryczynski G, Wölfler A, Beham-Schmid C, Thiele J.

Leukemia. 2017 Mar;31(3):768-769. doi: 10.1038/leu.2016.319. Epub 2016 Nov 29. No abstract available.

20.

IgD-λ myeloma with extensive free light-chain excretion: a diagnostic pitfall in the identification of monoclonal gammopathies.

Robier C, Piribauer M, Beham-Schmid C, Aubell K, Neubauer M.

Clin Chem Lab Med. 2017 Jun 27;55(7):e137-e139. doi: 10.1515/cclm-2016-0653. No abstract available.

PMID:
27816953
21.

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

Prochazka KT, Melchardt T, Posch F, Schlick K, Deutsch A, Beham-Schmid C, Weiss L, Gary T, Neureiter D, Klieser E, Greil R, Neumeister P, Egle A, Pichler M.

Br J Cancer. 2016 Nov 8;115(10):1264-1272. doi: 10.1038/bjc.2016.325. Epub 2016 Oct 20.

22.

Langerhans cell sarcoma: a case report and review of the literature.

Liu DT, Friesenbichler J, Holzer LA, Liegl-Atzwanger B, Beham-Schmid C, Leithner A.

Pol J Pathol. 2016 Jun;67(2):172-8. Review.

23.

Case Report: Epstein-Barr-Virus negative diffuse large B-cell lymphoma detected in a peri-prosthetic membrane.

Sunitsch S, Gilg M, Kashofer K, Leithner A, Liegl-Atzwanger B, Beham-Schmid C.

Diagn Pathol. 2016 Aug 18;11(1):80. doi: 10.1186/s13000-016-0533-z.

24.

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.

Gisslinger H, Jeryczynski G, Gisslinger B, Wölfler A, Burgstaller S, Buxhofer-Ausch V, Schalling M, Krauth MT, Schiefer AI, Kornauth C, Simonitsch-Klupp I, Beham-Schmid C, Müllauer L, Thiele J.

Leukemia. 2016 May;30(5):1126-32. doi: 10.1038/leu.2015.360. Epub 2015 Dec 29. Erratum in: Leukemia. 2017 Mar;31(3):774-775.

25.

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.

Troppan KT, Melchardt T, Wenzl K, Schlick K, Deutsch A, Bullock MD, Reitz D, Beham-Schmid C, Weiss L, Neureiter D, Tränkenschuh W, Greil R, Neumeister P, Egle A, Pichler M.

J Clin Pathol. 2016 Apr;69(4):326-30. doi: 10.1136/jclinpath-2015-203356. Epub 2015 Dec 7.

PMID:
26644520
26.

Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.

Wenzl K, Hofer S, Troppan K, Lassnig M, Steinbauer E, Wiltgen M, Zulus B, Renner W, Beham-Schmid C, Neumeister P, Deutsch A.

Tumour Biol. 2016 Apr;37(4):4785-9. doi: 10.1007/s13277-015-4322-1. Epub 2015 Oct 31.

PMID:
26518771
27.

Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study.

Kvasnicka HM, Beham-Schmid C, Bob R, Dirnhofer S, Hussein K, Kreipe H, Kremer M, Schmitt-Graeff A, Schwarz S, Thiele J, Werner M, Stein H.

Histopathology. 2016 May;68(6):905-15. doi: 10.1111/his.12871. Epub 2015 Nov 20.

PMID:
26402166
28.

miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.

Troppan K, Wenzl K, Pichler M, Pursche B, Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C, Neumeister P, Deutsch A.

Int J Mol Sci. 2015 Aug 5;16(8):18077-95. doi: 10.3390/ijms160818077.

29.

Mast cell infiltrates in vulvodynia represent secondary and idiopathic mast cell hyperplasias.

Regauer S, Eberz B, Beham-Schmid C.

APMIS. 2015 May;123(5):452-6. doi: 10.1111/apm.12372.

PMID:
25912132
30.

Anaphylaxis with clonal mast cells in normal looking skin - a new entity?

Bretterklieber A, Beham-Schmid C, Sturm GJ, Berghold A, Brezinschek R, Aberer W, Aberer E.

Allergy. 2015 Jul;70(7):864-72. doi: 10.1111/all.12634. Epub 2015 May 22.

PMID:
25899109
31.

Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.

Troppan K, Hofer S, Wenzl K, Lassnig M, Pursche B, Steinbauer E, Wiltgen M, Zulus B, Renner W, Beham-Schmid C, Deutsch A, Neumeister P.

PLoS One. 2015 Apr 9;10(4):e0123922. doi: 10.1371/journal.pone.0123922. eCollection 2015.

32.

Gα13 mediates human cytomegalovirus-encoded chemokine receptor US28-induced cell death in melanoma.

Joshi S, Wels C, Beham-Schmid C, Fukunaga-Kalabis M, Holmen SL, Otte M, Herlyn M, Waldhoer M, Schaider H.

Int J Cancer. 2015 Sep 15;137(6):1503-8. doi: 10.1002/ijc.29506. Epub 2015 Mar 16.

33.

The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

Troppan KT, Melchardt T, Deutsch A, Schlick K, Stojakovic T, Bullock MD, Reitz D, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Egle A, Pichler M.

Eur J Haematol. 2015 Dec;95(6):538-44. doi: 10.1111/ejh.12529. Epub 2015 Mar 26.

PMID:
25677782
34.

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Cerny-Reiterer S, Rabenhorst A, Stefanzl G, Herndlhofer S, Hoermann G, Müllauer L, Baumgartner S, Beham-Schmid C, Sperr WR, Mannhalter C, Sill H, Linkesch W, Arock M, Hartmann K, Valent P.

Oncotarget. 2015 Feb 20;6(5):3071-84.

35.

Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.

Reinisch A, Etchart N, Thomas D, Hofmann NA, Fruehwirth M, Sinha S, Chan CK, Senarath-Yapa K, Seo EY, Wearda T, Hartwig UF, Beham-Schmid C, Trajanoski S, Lin Q, Wagner W, Dullin C, Alves F, Andreeff M, Weissman IL, Longaker MT, Schallmoser K, Majeti R, Strunk D.

Blood. 2015 Jan 8;125(2):249-60. doi: 10.1182/blood-2014-04-572255. Epub 2014 Nov 18.

36.

Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.

Schulz E, Klampfl P, Holzapfel S, Janecke AR, Ulz P, Renner W, Kashofer K, Nojima S, Leitner A, Zebisch A, Wölfler A, Hofer S, Gerger A, Lax S, Beham-Schmid C, Steinke V, Heitzer E, Geigl JB, Windpassinger C, Hoefler G, Speicher MR, Boland CR, Kumanogoh A, Sill H.

Nat Commun. 2014 Oct 13;5:5191. doi: 10.1038/ncomms6191.

37.

Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.

Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.

Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.

PMID:
25171702
38.

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.

Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M.

Br J Cancer. 2014 Jul 8;111(1):55-60. doi: 10.1038/bjc.2014.277. Epub 2014 May 29.

39.

Alopecia universalis associated with cutaneous T cell lymphoma.

Miteva M, El Shabrawi-Caelen L, Fink-Puches R, Beham-Schmid C, Romanelli P, Kerdel F, Tosti A.

Dermatology. 2014;229(2):65-9. doi: 10.1159/000360759. Epub 2014 May 6.

PMID:
24821490
40.

NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.

Deutsch AJ, Rinner B, Wenzl K, Pichler M, Troppan K, Steinbauer E, Schwarzenbacher D, Reitter S, Feichtinger J, Tierling S, Prokesch A, Scheideler M, Krogsdam A, Thallinger GG, Schaider H, Beham-Schmid C, Neumeister P.

Blood. 2014 Apr 10;123(15):2367-77. doi: 10.1182/blood-2013-08-518878. Epub 2014 Feb 19.

41.

High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.

Seidel MG, Urban C, Sipurzynski J, Beham-Schmid C, Lackner H, Benesch M.

Br J Haematol. 2014 May;165(3):419-21. doi: 10.1111/bjh.12766. Epub 2014 Feb 1. No abstract available.

PMID:
24484542
42.

Benign mast cell hyperplasia and atypical mast cell infiltrates in penile lichen planus in adult men.

Regauer S, Beham-Schmid C.

Histol Histopathol. 2014 Aug;29(8):1017-25. doi: 10.14670/HH-29.1017. Epub 2014 Jan 9.

PMID:
24402730
43.

The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.

Troppan K, Deutsch A, Gerger A, Stojakovic T, Beham-Schmid C, Wenzl K, Neumeister P, Pichler M.

Br J Cancer. 2014 Jan 21;110(2):369-74. doi: 10.1038/bjc.2013.763. Epub 2013 Dec 19.

44.

Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.

Wiednig M, Beham-Schmid C, Kranzelbinder B, Aberer E.

Dermatology. 2013;227(1):67-71. doi: 10.1159/000351807. Epub 2013 Aug 31.

45.

Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).

Valent P, Aberer E, Beham-Schmid C, Fellinger C, Fuchs W, Gleixner KV, Greul R, Hadzijusufovic E, Hoermann G, Sperr WR, Wimazal F, Wöhrl S, Zahel B, Pehamberger H.

Am J Blood Res. 2013 May 5;3(2):174-80. Print 2013.

46.

[A rare case of undifferentiated thymus carcinoma with multiple metastasis].

Stanzel S, Beham-Schmid C, Aigner R.

Rofo. 2013 Apr;185(4):367-9. doi: 10.1055/s-0032-1330319. Epub 2012 Nov 29. German. No abstract available.

PMID:
23196832
47.

[Normal bone marrow and common reactive alterations].

Tzankov A, Dirnhofer S, Beham-Schmid C.

Pathologe. 2012 Nov;33(6):496-507. doi: 10.1007/s00292-012-1649-x. Review. German.

PMID:
22983101
48.

Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.

Hofmann NA, Ortner A, Jacamo RO, Reinisch A, Schallmoser K, Rohban R, Etchart N, Fruehwirth M, Beham-Schmid C, Andreeff M, Strunk D.

PLoS One. 2012;7(9):e44468. doi: 10.1371/journal.pone.0044468. Epub 2012 Sep 7.

49.

Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.

Deutsch AJ, Steinbauer E, Hofmann NA, Strunk D, Gerlza T, Beham-Schmid C, Schaider H, Neumeister P.

Mod Pathol. 2013 Feb;26(2):182-94. doi: 10.1038/modpathol.2012.134. Epub 2012 Aug 31.

50.

A case of upper extremity deep vein thrombosis due to Kikuchi Fujimoto disease.

Belaj K, Gary T, Eller P, Deutschmann H, Beham-Schmid C, Gorkiewicz G, Brodmann M.

Vasa. 2012 Sep;41(5):371-4. doi: 10.1024/0301-1526/a000224.

PMID:
22915535

Supplemental Content

Loading ...
Support Center